Geographic variation of MS incidence in two prospective studies of US women

Neurology

Volumn 53, Issue 8, 1999, Pages 1711-1718

  Hernán, Miguel A ^b   Olek, Michael J ^a   Ascherio, Alberto ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c NONE

Author keywords

Cohort study; Ethnic groups; Geography; Multiple sclerosis; United States

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; ENVIRONMENTAL FACTOR; ETHNIC GROUP; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; UNITED STATES;

EID: 0033544321     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.8.1711     Document Type: Article

References (40)

1. Kurtzke JF, Beebe GW, Norman JE. Epidemiology of multiple sclerosis in US veterans: 1. Race, sex, and geographic distribution. Neurology 1979;29:1228-1235.
2. Visscher BR, Detels R, Coulson AH, Malmgren RM, Dudley JP. Latitude, migration, and the prevalence of multiple sclerosis. Am J Epidemiol 1977;106:470-475.
3. Baum HM, Rothschild BB. The incidence and prevalence of reported multiple sclerosis. Ann Neurol 1981;10:420-428.
4. Minden SL, Marder WD, Harrold LN, Dor A. Multiple sclerosis: a statistical portrait. Cambridge: National Multiple Sclerosis Society, 1993:183.
5. Rosati G. Descriptive epidemiology of multiple sclerosis in Europe in the 1980s: a critical overview. Ann Neurol 1994;36: S164-S174.
6. Miller DH, Hammond SR, McLeod JG, Purdie G, Skegg DCG. Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental? J Neurol Neurosurg Psychiatry 1990;53:821-823.
7. McLeod JG, Hammond SR, Hallpike JF. Epidemiology of multiple sclerosis in Australia. Med J Aust 1994;160:117-122.
8. Granieri E, Casetta I, Tola M. Epidemiology of multiple sclerosis in Italy and southern Europe. Acta Neurol Scand 1995; 161(suppl):60-70.
9. Pina MA, Ara JR, Modrego PJ, Morales F, Capablo JL. Prevalence of multiple sclerosis in the sanitary district of Calatayud, Northern Spain: is Spain a zone of high-risk for this disease? Neuroepidemiology 1998;17:258-264.
10. Poser CM. The epidemiology of multiple sclerosis: a general overview. Ann Neurol 1994;36:S180-S193.
11. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
12. Rothman KJ, Greenland S. Measures of disease frequency. In: Rothman KJ, Greenland S, eds. Modern epidemiology. Philadelphia: Lippincott-Raven, 1998:29-46.
13. Stazio A, Paddison RM, Kurland LT. Multiple sclerosis in New Orleans, Louisiana, and Winnipeg, Manitoba, Canada: follow-up of a previous survey in New Orleans, and comparison between the patient populations in the two communities. J Chron Dis 1967;20:311-332.
14. Pryse-Phillips WEM. The incidence and prevalence of multiple sclerosis in Newfoundland and Labrador, 1960-84. Ann Neurol 1986;20:323-328.
15. Nelson LM, Hamman RF, Thompson DS, et al. Higher than expected prevalence of multiple sclerosis in northern Colorado: dependence on methodologic issues. Neuroepidemiology 1986;5:17-28.
16. Hader WJ, Elliot M, Ebers GC. Epidemiology of multiple sclerosis in London and Middlesex County, Ontario, Canada. Neurology 1988;38:617-621.
17. Wynn DR, Rodriguez M, O'Fallon M, Kurland LT. A reappraisal of the epidemiology of multiple sclerosis in Olmsted county, Minnesota. Neurology 1990;40:780-786.
18. Warren S, Warren KG. Prevalence, incidence, and characteristics of multiple sclerosis in Westlock County, Alberta, Canada. Neurology 1993;43:1760-1763.
19. Rice-Oxley M, Williams ES, Rees JE. A prevalence survey of multiple sclerosis in Sussex. J Neurol Neurosurg Psychiatry 1995;58:27-30.
20. Shepherd DI, Summers A. Prevalence of multiple sclerosis in Rochdale. J Neurol Neurosurg Psychiatry 1996;61:415-417.
21. McDonnell GV, Hawkins SA. An epidemiologic study of multiple sclerosis in northern Ireland. Neurology 1998;50:423-428.
22. Ford HL, Gerry E, Airey CM, Vail M, Johnson MH, Williams DRR. The prevalence of multiple sclerosis in the Leeds health authority. J Neurol Neurosurg Psychiatry 1998;64:605-610.
23. Ford HL, Johnson MH, Rigby AS. Variation between observers in classifying multiple sclerosis. J Neurol Neurosurg Psychiatry 1996;61:418. Letter.
24. Paty DW, Oger JJF, Kastrukoff LF, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 1988;38:180-185.
25. Lee KH, Hashimoto SA, Hooge JP, et al. Magnetic resonance-imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 1991;41:657-660.
26. Helmick CG, Wrigley JM, Zack MM, et al. Multiple sclerosis in Key West, Florida. Am J Epidemiol 1989;130:935-949.
27. Shepherd DI. Increased risk of multiple sclerosis among nurses and doctors. J Neurol Neurosurg Psychiatry 1991;54: 848-849. Letter.
28. Phadke JG, Downie AW. Epidemiology of multiple sclerosis in the north-east (Grampian region) of Scotland - an update. J Epidemiol Community Health 1987;41:5-13.
29. Dean G, Gray R. Do nurses and doctors have an increased risk of developing multiple sclerosis? J Neurol Neurosurg Psychiatry 1990;53:899-902.
30. Villard-Mackintosh L, Vessey MP. Oral contraceptives and reproductive factors in multiple sclerosis incidence. Contraception 1993;47:161-168.
31. Vessey M, Doll SR, Peto R, Johnson B, Wiggins P. A long-term follow-up study of women using different methods of contraception - an interim report. J Biosoc Sci 1976;8:373-427.
32. Davenport CB. Multiple sclerosis from the standpoint of geographic distribution and race. Arch Neurol Psychiatry 1922;8: 51-58.
33. Page WF, Kurtzke JF, Murphy FM, Norman JE. Epidemiology of multiple sclerosis in US veterans: 5. Ancestry and the risk of multiple sclerosis. Ann Neurol 1993;33:632-639.
34. Page WF, Mack TM, Kurtzke JF, Murphy FM, Norman JE. Epidemiology of multiple sclerosis in US veterans: 6. Population ancestry and surname ethnicity as risk factors for multiple sclerosis. Neuroepidemiology 1995;14:286-296.
35. Warren S, Svenson L, Woodhead S, Warren KG. Parental ancestry and risk of multiple sclerosis in Alberta, Canada. Neuroepidemiology 1996;15:1-9.
36. Edland A, Nyland H, Riise T, Larsen J. Epidemiology of multiple sclerosis in the county of Vestfold, eastern Norway: incidence and prevalence calculations. Acta Neurol Scand 1996; 93:104-109.
37. Midgard R, Riise T, Svanes C, Kvåele G, Nyland H. Incidence of multiple sclerosis in Møre and Romsdal, Norway from 1959 to 1991. Brain 1996;119:203-211.
38. Koch-Henriksen N, Brønnum-Hansen H, Hyllested K. Incidence of multiple sclerosis in Denmark 1948-1982: a descriptive nationwide study. Neuroepidemiology 1992;11:1-10.
39. Svenningsson A, Runmarker B, Lycke J, Andersen O. Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden. Acta Neurol Scand 1990;82:161-168.
40. Rothwell PM, Charlton D. High incidence and prevalence of multiple sclerosis in southeast Scotland: evidence of a genetic predisposition. J Neurol Neurosurg Psychiatry 1998;64:730-735.